clopidogrel has been researched along with Endotoxemia in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| de Mast, Q; El Messaoudi, S; Gerretsen, J; Gomes, M; Kiers, D; Kox, M; Pickkers, P; Riksen, NP; Rongen, GA; van der Heijden, WA; van der Ven, AJ; van Ede, L | 1 |
| Deng, HF; Li, T; Liu, K; Liu, MD; Miao, SY; Wang, XL; Xiao, XZ; Xiao, ZH | 1 |
| Brooks, MB; Cummings, KJ; Divers, TJ; Frye, AH; Fubini, SL; Ness, SL; Stokol, T; Watts, AE | 1 |
2 trial(s) available for clopidogrel and Endotoxemia
| Article | Year |
|---|---|
A randomised trial on the effect of anti-platelet therapy on the systemic inflammatory response in human endotoxaemia.
Topics: Adenosine; Administration, Intravenous; Adolescent; Adult; Aspirin; Cells, Cultured; Clopidogrel; Cytokines; Drug Therapy, Combination; Endotoxemia; Endotoxins; Healthy Volunteers; Humans; Inflammation; Inflammation Mediators; Male; Netherlands; Platelet Activation; Platelet Aggregation Inhibitors; Prospective Studies; Purinergic P2Y Receptor Antagonists; Ticagrelor; Ticlopidine; Time Factors; Treatment Outcome; Young Adult | 2017 |
Effects of clopidogrel on horses with experimentally induced endotoxemia.
Topics: Analysis of Variance; Animals; Body Temperature; Clopidogrel; Endotoxemia; Female; Fibrinogen; Flow Cytometry; Heart Rate; Horse Diseases; Horses; Lipopolysaccharides; P-Selectin; Platelet Activation; Platelet Aggregation Inhibitors; Respiratory Rate; Thrombelastography; Ticlopidine; Tumor Necrosis Factor-alpha; von Willebrand Factor | 2014 |
1 other study(ies) available for clopidogrel and Endotoxemia
| Article | Year |
|---|---|
Clopidogrel reduces lipopolysaccharide-induced inflammation and neutrophil-platelet aggregates in an experimental endotoxemic model.
Topics: Animals; Blood Platelets; CD40 Ligand; Clopidogrel; Endotoxemia; Inflammation; Interleukin-1beta; Lipopolysaccharides; Mice, Inbred BALB C; Models, Animal; Neutrophils; P-Selectin; Platelet Aggregation Inhibitors; Pneumonia; Purinergic P2Y Receptor Antagonists; Thromboplastin; Tumor Necrosis Factor-alpha | 2019 |